ACP5 and rheumatoid arthritis: The results presented here are in line with a previous study showing higher levels of bone resorption markers (such as CTX-I, tartrate-resistant acid phosphatase 5b and cathespin K) in the serum of ACPA-positive as compared to ACPA-negative newly diagnosed untreated RA patients [11].